跳至主要内容
临床试验/NCT02134574
NCT02134574招募中不适用

Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Survival with 2 years

研究概览

简要总结

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

详细描述

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy in LR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18
  • Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent
  • Having signed an informed consent
  • Affiliated with a social security scheme

排除标准

  • Minor or major protected
  • Patients who have received treatment for hematological pathology

研究组 & 干预措施

hematologic malignancy

hematologic malignancy with a sampling of blood

干预措施: hematologic malignancy (Biological)

结局指标

主要结局

Survival with 2 years

时间窗: 2 years

Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30

次要结局

  • Survival with 5 years(5 years)
  • Survival with 10 years(10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验